about
Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase CMorphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activationReceptorphin: a conserved peptide derived from the sequence of the opioid receptor, with opioid displacement activity and potent antiproliferative actions in tumor cellsTargeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro studyRhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentialsRecent advances in epidural analgesia.Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site.Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.Toll-like receptor 9 is required for opioid-induced microglia apoptosis.Immunity, hormones, and the brain.Disgust as an adaptive system for disease avoidance behaviourOpioid pharmaceuticals and addiction: the issues, and research directions seeking solutions.A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.Neuropsychopharmacological understanding for therapeutic application of morphinansPharmacokinetics of transdermal buprenorphine patch in the elderly.Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.Opiates and the development of post-injury complications: a review.Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.Lidocaine Infusion: A Promising Therapeutic Approach for Chronic PainClinical Approach to the Treatment of Painful Diabetic Neuropathy.Clinical strategies for the primary health care professional to minimize prescription opioid abuse.In vitro end points for the assessment of cellular immune response-modulating drugs.Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence.Chronic opioid therapy in long-term cancer survivors.Gut Homeostasis, Microbial Dysbiosis, and Opioids.Protective effects of the sigma agonist Pre-084 in the rat retina.Opiate use inhibits TLR9 signaling pathway in vivo: possible role in pathogenesis of HIV-1 infection.Opioid analgesics stop the development of clostridial gas gangrene.Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery.Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection.The effects of alcohol on the recognition of facial expressions and microexpressions of emotion: enhanced recognition of disgust and contempt.
P2860
Q24673814-64E26649-33E7-4E0F-B681-CA3FF277A5F6Q24677648-A7FDDC16-3B34-482B-89F8-4156E71E8FECQ24795856-D3A46276-C2FF-46B1-9E2B-897676CC311BQ28487323-EB09B907-0E89-4AC2-8376-64D6BEA55B82Q30452156-C7B9E0EC-94B6-4D2C-B40E-FD3BEC7596A7Q30472078-4525472D-48CB-4389-A586-06D2F9A5D1B6Q30954151-EC504AAE-01BB-49DA-8C4F-3B87FDB0F7D7Q33597153-C3727D56-10DA-4E84-8D05-686544D274ABQ33705809-5052F84A-0FB7-4691-9CBD-49F55168990DQ33895294-3839F407-4F56-49EE-A7B5-33E11131134BQ34291164-8C6B983C-1801-410A-9CC5-4EA1E2E13BAFQ34454999-9583CA58-B1AA-470D-89A3-56B57794E1A1Q34773536-16F76295-742A-41F1-BED7-029372BB3B32Q35576767-99F679C6-E68C-4745-B03B-2658EC1CE479Q36102944-EDEF0C3A-318D-4452-B7CB-0FC15A4D096CQ36542638-BF8F3FA3-3E5A-4DFB-9C29-ABE07AE0F816Q36694953-A476A93C-79AF-4156-9E90-7D746CBC3D44Q37053834-757C5381-B769-47CF-8E67-0B987A4C6406Q37349921-565AC94F-C5CE-40EC-B258-7E5CB6F50394Q37400166-D0E947AF-5CC3-4B0F-8831-94247AA1650CQ37662423-F10C7064-B362-41FC-A43B-E2F23D4F2128Q37895130-F4CFF57F-1E45-4C26-ABA2-00D7408D5C31Q38018218-08ABBD39-A701-4D3A-9974-00873EF9FAB5Q38088820-DB40C280-3CC9-4FD7-8455-8C99587BF601Q38417258-572DFF8B-5029-4067-A8B8-C3CDCD06CC79Q38904553-8BDAB02B-7AA1-4FBC-883A-51730BB7188BQ40432327-80B436E7-CE0A-418C-BDC0-9C6A16CDCFB1Q41131353-61061FB5-1B92-4E3D-8F6C-6D4120554CADQ42376016-631DA336-3AAB-4772-B873-36DF8F2167CBQ44343466-DA392444-AA14-4895-A621-C2B274A23E4FQ46191475-68CF8531-36C9-4B30-BFB9-237D53D81580Q46313449-5849C64A-D987-43B9-A9F9-45D02005C6D6Q47684937-5C4AFB08-9C05-4211-8C50-6CC162523A7C
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Effects of opioids on the immune system.
@ast
Effects of opioids on the immune system.
@en
Effects of opioids on the immune system.
@nl
type
label
Effects of opioids on the immune system.
@ast
Effects of opioids on the immune system.
@en
Effects of opioids on the immune system.
@nl
prefLabel
Effects of opioids on the immune system.
@ast
Effects of opioids on the immune system.
@en
Effects of opioids on the immune system.
@nl
P2860
P356
P1476
Effects of opioids on the immune system.
@en
P2860
P2888
P304
P356
10.1007/BF02532379
P577
1996-11-01T00:00:00Z
P6179
1019258608